Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction
NCT07880743Phase 3Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in anterior cruciate ligament injury, postoperative pain. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
anterior cruciate ligament injurypostoperative pain
Beyond the preview
Go deeper on NCT07880743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880743.